Inventor · disambiguated record
Alan Martin Birch
Also filed as: BIRCH ALAN M · BIRCH ALAN MARTIN
15 granted patents·15 pending applications·108 citations·filing 1993–2012
92Inventor score
Top patents by PatentIndex Score
30 records- 0188US7795283B2Oxadiazole derivative as DGAT inhibitorsASTRAZENECA AB·Filed 2005·Granted Sep 14, 2010·15 cites·6 claims
- 0285US7749997B2Pyrimido [4,5-B] -Oxazines for use as DGAT inhibitorsASTRAZENECA AB·Filed 2006·Granted Jul 6, 2010·13 cites·4 claims
- 0382US5627191ATherapeutic agentsBOOTS CO PLC·Filed 1993·Granted May 6, 1997·32 cites·5 claims
- 0477US8188092B2Substituted pyrazines as DGAT-1 inhibitorsBIRCH ALAN MARTIN·Filed 2010·Granted May 29, 2012·7 cites·13 claims
- 0576US7994179B2Carbamoyl compounds as DGAT1 inhibitors 190ASTRAZENECA AB·Filed 2008·Granted Aug 9, 2011·5 cites·10 claims
- 0668US7129249B2Heterocyclic amide derivatives as inhibitors of glycogen phoshorylaseASTRAZENECA AB·Filed 2003·Granted Oct 31, 2006·3 cites·15 claims
- 0764US6353002B2Therapeutic agentsKNOLL AG·Filed 2000·Granted Mar 5, 2002·2 cites·19 claims
- 0859US7276517B2Heterocyclic amide derivatives as inhibitors of glycogen phosphorylaseASTRAZENECA AB·Filed 2006·Granted Oct 2, 2007·0 cites·2 claims
- 0953US6218405B1Heteroarylsulfonamide derivatives and pharmaceutical compositions containing themKNOLL AG·Filed 1997·Granted Apr 17, 2001·12 cites·6 claims
- 1051US5935973AHeterocyclcarboxamide derivatives and their use as therapeutic agentsKNOLL AG·Filed 1996·Granted Aug 10, 1999·11 cites·11 claims
- 1146US2010184813A1Chemical compounds 553ASTRAZENECA AB·Filed 2009·Application pending·0 cites
- 1245US2011092547A1Chemical compounds 979BIRCH ALAN MARTIN·Filed 2008·Application pending·0 cites
- 1345US2006211760A1Indolamide derivatives which possess glycogen phosphorylase inhibitory activityASTRAZENECA AB·Filed 2004·Application pending·0 cites
- 1444US8017603B2Pyrimido [4,5-B]-oxazines for use as DGAT inhibitorsASTRAZENECA AB·Filed 2010·Granted Sep 13, 2011·0 cites·10 claims
- 1544US7169927B2Indole-amide derivatives and their use as glycogen phosphorylase inhibitorsASTRAZENECA AB·Filed 2003·Granted Jan 30, 2007·0 cites·4 claims
- 1643US2010137397A1Chemical CompoundsASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 1742US2008009512A1Tetrahydroquinolones and Aza-Analogues Thereof for Use as Dpp-IV Inhibitors in the Treatment of DiabetesASTRAZENECA AB·Filed 2005·Application pending·0 cites
- 1842US2010160397A1Oxazole derivatives and their use in the treatment of diabetes and obesityBIRCH ALAN MARTIN·Filed 2007·Application pending·0 cites
- 1942US2010317653A1Oxadiazole derivatives as dgat inhibitorsASTRAZENECA AB·Filed 2010·Application pending·0 cites
- 2041US6107310AHeteroarylcarboxamide derivatives for treating CNS disordersKNOLL AG·Filed 1996·Granted Aug 22, 2000·5 cites·23 claims
- 2141US2009197926A1Benzimidazoles and their use for the treatment of diabetesBIRCH ALAN MARTIN·Filed 2007·Application pending·0 cites
- 2241US2008064691A1Heterocyclic Amide Derivatives Which Possess Glycogen Phosphorylase Inhibitory ActivityASTRAZENECA AB·Filed 2004·Application pending·0 cites
- 2340US2012289520A1Chemical compounds 785BIRCH ALAN MARTIN·Filed 2012·Application pending·0 cites
- 2438US2009124682A1Indan-Amide Derivatives with Glycogen Phosphorylase Inhibitory ActivityBIRCH ALAN MARTIN·Filed 2006·Application pending·0 cites
- 2537US6201004B1Dioxino derivatives and their use as therapeutic agentsKNOLL AG·Filed 1998·Granted Mar 13, 2001·2 cites·21 claims
- 2637US2012108602A1Carbamoyl Compounds as DGAT1 Inhibitors 190BAUER UDO ANDREAS·Filed 2011·Application pending·0 cites
- 2736US2004039023A1Therapeutic agentsFiled 2001·Application pending·0 cites
- 2836US2011251173A1Chemical compoundsASTRAZENECA AB·Filed 2011·Application pending·0 cites
- 2934US6136825ASulfonamide compounds having 5-HT receptor activityKNOLL AG·Filed 1997·Granted Oct 24, 2000·1 cites·6 claims
- 3031US2011065706A1Therapeutic Agents 812ASTRAZENECA AB·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Alan Martin Birch files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →